INDETERMINATE LESIONS
Clinical trials for INDETERMINATE LESIONS explained in plain language.
Never miss a new study
Get alerted when new INDETERMINATE LESIONS trials appear
Sign up with your email to follow new studies for INDETERMINATE LESIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Light-Activated drug could halt rare eye cancer growth
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people with a rare eye cancer (choroidal melanoma) or suspicious spots that could turn into cancer. The drug is activated by a laser to target and destroy cancer cells. About 100 participants will receive eith…
Matched conditions: INDETERMINATE LESIONS
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
How does eye cancer affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. About 15 people already in a larger Phase 3 trial will answer questionnaires about their well-being over two years. No new drugs or procedures are tested—only information is collected.
Matched conditions: INDETERMINATE LESIONS
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated May 26, 2026 07:32 UTC